Welcome to BionFarming - Revolutionary Biotechnology for a Sustainable Future
BionFarming: Revolutionizing Biopharmaceutical Production with Cyanobacteria
Welcome to BionFarming, where cutting-edge biotechnology meets sustainability and innovation. Our unique platform leverages the extraordinary power of cyanobacteria to revolutionize the production of recombinant proteins, enzymes, and biopharmaceuticals. With a strong foundation in Molecular Farming, we offer a scalable, cost-effective, and environmentally friendly alternative to traditional systems, designed to meet the growing demands of the biopharma industry.
Start realising your development project today
What We Offer: A New Standard in Molecular Farming
At BionFarming, we go beyond conventional Molecular Farming by utilizing genetically enhanced cyanobacteria in our patented CyanoSphere cultivation systems. This breakthrough platform integrates closed cultivation systems with advanced Carbon-Concentrating Mechanisms (CCM) and Nutrient Reservoir Technology (NRT), creating an optimized environment for the production of complex biopharmaceuticals. Our system is designed to outperform traditional platforms like E. coli and plant-based systems in both efficiency and sustainability.
Key Advantages of BionFarming’s Platform:
High Efficiency, No Renaturation Required: Unlike E. coli and plant-based systems that often require costly and time-consuming protein renaturation, our cyanobacteria produce fully bioactive proteins, including those with complex disulfide bonds, directly in their native form.
Cost-Effective Carbon Utilization: Thanks to the CCM in cyanobacteria, our platform efficiently fixes CO₂ from the environment, drastically reducing operational costs. No expensive carbon sources are needed, which makes our system not only sustainable but also economically superior.
Nutrient Reservoir Technology (NRT): Inspired by nature, NRT enables cyanobacteria to store and manage nutrients, ensuring continuous, high-yield production, even under suboptimal conditions. This reduces the need for frequent nutrient replenishment and optimizes growth cycles.
Bubble-Free Gas Exchange: Our closed reactors eliminate gas exchange inefficiencies, ensuring maximum CO₂ utilization with minimal loss, further cutting down operational costs.
Production Capabilities
1. Recombinant Proteins: Our platform specializes in the efficient production of therapeutic proteins such as Interferon alpha 2 and Defensins, proteins that require correct folding and post-translational modifications.
2. Enzymes for Industry: We manufacture industrial enzymes like proteases and amylases, with a focus on high activity and stability, ideal for the pharmaceutical, food, and cosmetic industries.
3. Biopharmaceuticals: We produce complex biosimilars and biobetters, including antibody fragments and fusion proteins. Our platform’s ability to handle disulfide-rich proteins gives it a major edge over conventional systems.
4. Antimicrobial Peptides (AMPs) and Defensins: With the rise of antimicrobial resistance, our platform is perfectly suited for the production of Defensins and other AMPs, offering new solutions in the fight against infections.
Why Choose BionFarming?
Resilience & Flexibility: Our platform is robust, operating in controlled, sterile environments free from the risks of external contamination. This is a key improvement over open-field plant-based systems, which face challenges like weather variability, pest contamination, and low yields.
IP Flexibility: Unlike many established systems, where the best applications are already patented, our cyanobacteria-based technology operates in an IP space with fewer restrictions, giving you room to innovate without the threat of legal complications.
Sustainability: Our phototrophic cultivation process utilizes light and CO₂, making it a sustainable choice for biopharma. By reducing reliance on expensive resources, we offer a more eco-friendly production process without compromising on productivity.
Solving the Challenges of Molecular Farming
Molecular Farming in plants faces significant regulatory, logistical, and cost-related hurdles. Field-grown genetically modified plants are restricted in many countries, and the challenges of open-environment cultivation, such as weather dependency, contamination, and low yields, limit their viability for large-scale biopharmaceutical production.
BionFarming solves these issues with its closed system approach:
- No regulatory roadblocks associated with field-grown GMOs.
- Higher yields thanks to fast-growing cyanobacteria with fewer metabolic restrictions than plants.
- Efficient downstream processing: Cyanobacteria produce fewer cellular debris than plants, making protein purification easier, faster, and more cost-effective.
The Future of Biopharmaceuticals
We believe that our cyanobacterial platform represents the next generation of Molecular Farming. With faster growth cycles, reduced costs, and an environmentally sustainable approach, BionFarming offers an unparalleled solution for companies looking to scale up their production of therapeutic proteins, enzymes, and biosimilars. Whether you’re producing antimicrobial peptides, therapeutic enzymes, or biopharmaceuticals, BionFarming provides the reliability, efficiency, and flexibility you need to stay competitive in today’s rapidly evolving biopharma market.
Let’s Innovate Together
Join us in shaping the future of Molecular Farming. Discover how BionFarming’s advanced cyanobacterial technology can transform your production pipeline and deliver sustainable, high-quality biopharmaceuticals at scale.
Contact us today to learn more about our solutions or to discuss partnership opportunities.
Start realising your development project today
BionFarming in a nutshell
Harnessing the Power of Cyanobacteria for a Sustainable Biopharma Future
At BionFarming, our mission is to revolutionize the biopharmaceutical industry by leveraging the power of cyanobacteria for sustainable, scalable, and cost-effective production. Our vision is to create a world where essential biopharmaceuticals are produced efficiently and affordably, without compromising the environment. Our team of experts in Molecular Farming, biotechnology, and environmental science is dedicated to solving the most pressing challenges in biopharmaceutical production.